Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
Cipponi A, Wieers G, van Baren N, Coulie PG. Cipponi A, et al. Among authors: coulie pg. Cancer Immunol Immunother. 2011 Aug;60(8):1153-60. doi: 10.1007/s00262-011-1026-2. Epub 2011 May 7. Cancer Immunol Immunother. 2011. PMID: 21553145 Review.
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells.
Coulie PG, Somville M, Lehmann F, Hainaut P, Brasseur F, Devos R, Boon T. Coulie PG, et al. Int J Cancer. 1992 Jan 21;50(2):289-97. doi: 10.1002/ijc.2910500220. Int J Cancer. 1992. PMID: 1730522
High- and low-affinity receptors for murine interleukin 6. Distinct distribution on B and T cells.
Coulie PG, Stevens M, Van Snick J. Coulie PG, et al. Eur J Immunol. 1989 Nov;19(11):2107-14. doi: 10.1002/eji.1830191121. Eur J Immunol. 1989. PMID: 2574680
Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma.
Weynants P, Wauters P, Coulie PG, Van den Eynde B, Symann M, Boon T. Weynants P, et al. Among authors: coulie pg. Cancer Immunol Immunother. 1988;27(3):228-32. doi: 10.1007/BF00205444. Cancer Immunol Immunother. 1988. PMID: 2846175
Synergistic activation of human T cells by interleukin 1 and interleukin 6.
Houssiau FA, Coulie PG, Olive D, Van Snick J. Houssiau FA, et al. Among authors: coulie pg. Eur J Immunol. 1988 Apr;18(4):653-6. doi: 10.1002/eji.1830180427. Eur J Immunol. 1988. PMID: 3130269
High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
Coulie PG, Vanhecke A, Van Damme J, Cayphas S, Poupart P, De Wit L, Content J. Coulie PG, et al. Eur J Immunol. 1987 Oct;17(10):1435-40. doi: 10.1002/eji.1830171008. Eur J Immunol. 1987. PMID: 3500055
Antigens recognized on human tumors by cytolytic T lymphocytes: towards vaccination?
Coulie PG. Coulie PG. Stem Cells. 1995 Jul;13(4):393-403. doi: 10.1002/stem.5530130410. Stem Cells. 1995. PMID: 7549898 Review.
From defined human tumor antigens to effective immunization?
Boon T, Gajewski TF, Coulie PG. Boon T, et al. Among authors: coulie pg. Immunol Today. 1995 Jul;16(7):334-6. doi: 10.1016/0167-5699(95)80149-9. Immunol Today. 1995. PMID: 7576068 Review. No abstract available.
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
Coulie PG, Lehmann F, Lethé B, Herman J, Lurquin C, Andrawiss M, Boon T. Coulie PG, et al. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7976-80. doi: 10.1073/pnas.92.17.7976. Proc Natl Acad Sci U S A. 1995. PMID: 7644523 Free PMC article.
A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T. van der Bruggen P, et al. Among authors: coulie pg. Eur J Immunol. 1994 Dec;24(12):3038-43. doi: 10.1002/eji.1830241218. Eur J Immunol. 1994. PMID: 7805731
144 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page